Cargando…
Remifentanil-based analgesia and sedation facilitates more rapid and predictable time to neurological assessments
Autores principales: | Karabinis, A, Mandragos, K, Stergiopoulos, S, Komnos, A, Soukup, J, Speelberg, B, Kirkham, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099823/ http://dx.doi.org/10.1186/cc2703 |
Ejemplares similares
-
The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma
por: Stergiopoulos, S, et al.
Publicado: (2004) -
Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]
por: Karabinis, Andreas, et al.
Publicado: (2004) -
Decreased time on mechanical ventilation using remifentanil-based analgesia and sedation
por: Malbrain, M, et al.
Publicado: (2004) -
Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
por: Karabinis, A, et al.
Publicado: (2004) -
Remifentanil in neurosurgical patients in the intensive care unit
por: Koukoulitsios, G, et al.
Publicado: (2005)